Neotous Sustained Release Tablet (Levodropropizine)

Adult dose

Adults: 1 tablet (equivalent to 90mg of levodropropizine) per dose, administered orally twice daily. This is an extended-release formulation; swallow it whole without splitting or crushing.

This medication should not be used by individuals allergic to this drug or any of its ingredients. Patients with diseases that increase bronchial mucus secretion should also avoid taking this product. Individuals with certain genetic disorders, such as impaired ciliary function, should refrain from using this medication. Women who are pregnant or may become pregnant, as well as breastfeeding women, should not take this medication. Patients with severely impaired liver function should also avoid this medication. Since this medication contains lactose, individuals with lactose intolerance or related genetic disorders should avoid taking it. Patients with severe heart failure or very poor kidney function should use this medication with caution. Elderly individuals and children should also be cautious when using this medication. This medication may occasionally cause gastrointestinal symptoms, such as nausea, dyspepsia, and constipation. Central nervous system symptoms, such as drowsiness, headache, and dizziness, are commonly reported. Occasionally, symptoms such as eyelid swelling or orthostatic dizziness may also appear. There may be an increase in white blood cells or elevated liver function test values in urine tests, so caution is necessary. Care should be taken when driving or operating machinery during the use of this medication, especially when taken with alcohol, as drowsiness may worsen. The side effects may be exacerbated when used with sedatives, so caution is required. It is preferable to administer this medication in a formulation other than sustained release for children. The medication should be stored out of reach of children, and transferring it to other containers may reduce its quality, so caution is needed.

• nausea
• indigestion
• constipation
• drowsiness
• headache
• dizziness
• positional vertigo
• eyelid swelling
• increased white blood cells in urine
• elevated ALT

This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. This will help preserve the medication’s efficacy and prevent degradation.

Appearance

White rectangular sustained release tablet

Package unit

300 tablets/bottle, 30 tablets/bottle